Deazapurines and uses thereof
US7314936B2 · kind B2 · utility
5Cited by
19References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 7, 2003 |
| Grant date | Jan 1, 2008 |
| Priority date | — |
| Expiry date | Apr 4, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds having formula (I), wherein R1, R2, R3 and n are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof in the treatment of inflammatory or autoimmune and proliferative disorders and as inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction generally
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.